Thomas E. Witzig
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
Papers in
-
- Blood Coagulation and Thrombosis Mechanisms 2
- Acute Myeloid Leukemia Research 1
- Multiple Myeloma Research and Treatments 1
- Surgery 1
- Co-authors
- W. Michael O’Fallon (1 shared paper)Robert A. Kyle (1 shared paper)Daniel Silverman (1 shared paper)William D. Erwin (1 shared paper)Stewart Spies (1 shared paper)Christine A. White (1 shared paper)William L. Dunn (1 shared paper)Magnus Dahlbom (1 shared paper)
- Journals
- British Journal of Haematology (1 paper)American Journal of Hematology (1 paper)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)Leukemia & lymphoma (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Thomas E. Witzig
4 papers receiving 300 citations
Peers
Comparison fields: 5 of 51
- Hematology 93
- Radiology, Nuclear Medicine and Imaging 156
- Pathology and Forensic Medicine 99
- Genetics 50
- Radiation 33
Countries citing papers authored by Thomas E. Witzig
This map shows the geographic impact of Thomas E. Witzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Witzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Witzig more than expected).
Fields of papers citing papers by Thomas E. Witzig
This network shows the impact of papers produced by Thomas E. Witzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Witzig. The network helps show where Thomas E. Witzig may publish in the future.
Co-authors
The 23 scholars most cited alongside Thomas E. Witzig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 189 | |
| 2 | 1994 | 75 | |
| 3 | 1999 | 31 | |
| 4 | 1999 | 20 |
About Thomas E. Witzig
Thomas E. Witzig is a scholar working on Hematology, Surgery, Molecular Biology, Pathology and Forensic Medicine and Neurology, having authored 4 papers that have together received 315 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Acute Myeloid Leukemia Research (1 paper), Multiple Myeloma Research and Treatments (1 paper), Amyloidosis: Diagnosis, Treatment, Outcomes (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Hematology (93 citations), Radiology, Nuclear Medicine and Imaging (156 citations), Pathology and Forensic Medicine (99 citations), Genetics (50 citations) and Radiation (33 citations). Thomas E. Witzig has collaborated with scholars based in United States and Switzerland. Frequent co-authors include W. Michael O’Fallon, Robert A. Kyle, Daniel Silverman, William D. Erwin, Stewart Spies, Christine A. White, William L. Dunn, Magnus Dahlbom, Kastytis C. Karvelis and Gregory A. Wiseman. Their work appears in journals such as British Journal of Haematology, American Journal of Hematology, European Journal of Nuclear Medicine and Molecular Imaging and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.